These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31853610)

  • 41. Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
    Tynan M; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill SC; Jandorf L; Kelly SP; Heinzmann J; Kelleher S; Poggi E; Schwartz MD
    Breast Cancer Res Treat; 2020 Feb; 180(1):177-185. PubMed ID: 31894446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of contralateral prophylactic mastectomy among elderly patients in the United States.
    Marmor S; Altman AM; Mayleben WT; Hui JYC; Denbo JW; Jensen EH; Tuttle TM
    Breast Cancer Res Treat; 2019 Aug; 177(1):175-183. PubMed ID: 31140081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Issues of regret in women with contralateral prophylactic mastectomies.
    Montgomery LL; Tran KN; Heelan MC; Van Zee KJ; Massie MJ; Payne DK; Borgen PI
    Ann Surg Oncol; 1999 Sep; 6(6):546-52. PubMed ID: 10493622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Financial toxicity and contralateral prophylactic mastectomy: an analysis using propensity score methods.
    Asaad M; Boukovalas S; Chu CK; Lin YL; Checka CM; Clemens MW; Greenup RA; Offodile AC
    Breast Cancer Res Treat; 2020 Oct; 183(3):649-659. PubMed ID: 32691378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Indications for Contralateral Prophylactic Mastectomy: A Consensus Statement Using Modified Delphi Methodology.
    Wright FC; Look Hong NJ; Quan ML; Beyfuss K; Temple S; Covelli A; Baxter N; Gagliardi AR
    Ann Surg; 2018 Feb; 267(2):271-279. PubMed ID: 28594745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
    Rosenberg SM; Sepucha K; Ruddy KJ; Tamimi RM; Gelber S; Meyer ME; Schapira L; Come SE; Borges VF; Golshan M; Winer EP; Partridge AH
    Ann Surg Oncol; 2015 Nov; 22(12):3809-15. PubMed ID: 25930247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.
    Graves KD; Peshkin BN; Halbert CH; DeMarco TA; Isaacs C; Schwartz MD
    Breast Cancer Res Treat; 2007 Sep; 104(3):321-9. PubMed ID: 17066320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
    Terkelsen T; Rønning H; Skytte AB
    Acta Oncol; 2020 Jan; 59(1):60-65. PubMed ID: 31379231
    [No Abstract]   [Full Text] [Related]  

  • 49. EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.
    Schmidt MK; Kelly JE; Brédart A; Cameron DA; de Boniface J; Easton DF; Offersen BV; Poulakaki F; Rubio IT; Sardanelli F; Schmutzler R; Spanic T; Weigelt B; Rutgers EJT
    Eur J Cancer; 2023 Mar; 181():79-91. PubMed ID: 36641897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.
    D'Agostino TA; Brewster AM; Peterson SK; Bedrosian I; Parker PA
    Transl Behav Med; 2020 May; 10(2):347-354. PubMed ID: 30561744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?
    Mamtani A; Sjoberg DD; Vincent A; Ehdaie B; Malhotra D; Vickers A; Morrow M
    Breast Cancer Res Treat; 2023 May; 199(1):119-126. PubMed ID: 36881270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.
    Katz SJ; Hawley ST; Hamilton AS; Ward KC; Morrow M; Jagsi R; Hofer TP
    JAMA Surg; 2018 Jan; 153(1):29-36. PubMed ID: 28903158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma.
    Yu TJ; Liu YY; Hu X; Di GH
    J Surg Oncol; 2018 Nov; 118(6):928-935. PubMed ID: 30311653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
    Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
    Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
    Davies KR; Brewster AM; Bedrosian I; Parker PA; Crosby MA; Peterson SK; Shen Y; Volk RJ; Cantor SB
    Breast Cancer Res; 2016 Sep; 18(1):93. PubMed ID: 27650678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
    Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
    J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contralateral prophylactic mastectomy (CPM): A systematic review of patient reported factors and psychological predictors influencing choice and satisfaction.
    Ager B; Butow P; Jansen J; Phillips KA; Porter D;
    Breast; 2016 Aug; 28():107-20. PubMed ID: 27290619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The implementation of a decision aid for women with early-stage breast cancer considering contralateral prophylactic mastectomy: A pilot study.
    Jansen J; Serafimovska A; Glassey R; Zdenkowski N; Saunders C; Porter D; Butow P
    Patient Educ Couns; 2022 Jan; 105(1):74-80. PubMed ID: 34034935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prophylactic mastectomy for the prevention of breast cancer.
    Lostumbo L; Carbine NE; Wallace J
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002748. PubMed ID: 21069671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends of incidence and mortality in metaplastic breast cancer and the effect of contralateral prophylactic mastectomy: A population-based study.
    Wu P; Chang H; Wang Q; Shao Q; He D
    Asian J Surg; 2024 Jan; 47(1):394-401. PubMed ID: 37739898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.